Back to mobile site

Mizuho Reiterates Outperform Rating on Ideaya Biosciences (IDYA)

September 25, 2024 6:56 AM EDT Send to a Friend
Mizuho analyst Graig Suvannavejh reiterated an Outperform rating and $55.00 price target on Ideaya Biosciences (NASDAQ: IDYA).The analyst commented: "Yesterday ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login